• OPEN AN ACCOUNT
Indian Indices
Sensex
82,344.68 487.20
( 0.60%)
Global Indices
Nasdaq
49,020.90 -412.51
(-0.83%)
Dow Jones
6,999.25 28.02
(0.40%)
Hang Seng
53,273.44 -60.10
(-0.11%)
Nikkei 225
10,215.77 66.92
(0.66%)
Forex
USD-INR
91.65 0.01
(0.01%)
EUR-INR
108.74 0.34
(0.32%)
GBP-INR
125.29 0.27
(0.21%)
JPY-INR
0.59 0.01
(1.05%)

EQUITY - MARKET SCREENER

Influx Healthtech Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
93847
INE0MYZ01012
36.3489357
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INFLUX
35.26
470.99
EPS(TTM)
Face Value()
Div & Yield %
5.77
10
0
 

Amal Ltd - Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results With Limited Review Report For The Quarter / Six Months Ended September 30 2025
Oct 15,2025
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are submitting unaudited standalone and consolidated financial results of the Company for the quarter / six months ended September 30 2025 along with limited review reports. Integrated filling (Financials) pursuant to the SEBI circular no SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31 2024 is being submitted separately in xbrl format in accordance with relevant circular issued by the stock exchange. The above have been taken on record by the Board of Directors of the Company today at their meeting held from 11:00 am to 12:25 pm. Kindly acknowledge and take note of the same on your record.